P. Ariniello

Eradication of large colon tumor xenografts by targeted delivery of maytansinoids.

N. Kedersha, R. Chari, W. Blättler, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Evaluation of the systemic toxicity and pharmacokinetics of the immunoconjugate anti-B4-blocked ricin in non-human primates. Delivered by multiple bolus injections and by continuous infusion.

J. Taylor, S. Shah, V. Goldmacher, 1993, International journal of immunopharmacology.

Expression of the receptor‐linked protein tyrosine phosphatase LAR: proteolytic cleavage and shedding of the CAM‐like extracellular region.

D. Adler, H. Saito, J. M. Munro, 1992, The EMBO journal.

Identification of tissue-infiltrating lymphocytes expressing PEN5, a mucin-like glycoprotein selectively expressed on natural killer cells.

P. Anderson, M. Munroe, É. Vivier, 1995, The American journal of pathology.

Elimination of neuroblastoma and small-cell lung cancer cells with an anti-neural cell adhesion molecule immunotoxin.

C Perreault, C. Perreault, Denis Roy, 1996, Journal of the National Cancer Institute.

Divalent hapten-induced intestinal anaphylaxis in the mouse enhances macromolecular uptake from the stomach.

R. Hatz, W. Walker, R. Kleinman, 1990, Gastroenterology.

Divalent hapten-induced intestinal anaphylaxis in the mouse: uptake and characterization of a bystander protein.

R. Hatz, W. Walker, R. Kleinman, 1989, Immunology.

Immunotoxin therapy of small-cell lung cancer: a phase I study of N901-blocked ricin.

D. Esseltine, J. Ritz, T. Lynch, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Use of the immunotoxin N901‐blocked ricin in patients with small‐cell lung cancer

P. Wen, J. Ritz, J. Shefner, 1994, International journal of cancer. Supplement = Journal international du cancer. Supplement.